Search Tag: non-vitamin K antagonist oral anticoagulants

Cardiology Management


2017 20 Jun

Guidelines regarding the management of atrial fibrillation have been published by major cardiovascular societies. Although the majority of recommendations within the current guidelines are similar, important differences are observed particularly when the quality of evidence is moderate or low, according to a review article to appear in the Canadian...Read more

Executive Health Management


2019 02 Oct

Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines...Read more

ICU Management


2023 01 Aug

There is a lack of evidence-based haemostatic treatment for intracerebral haemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOACs). Tranexamic acid (TXA) is an antifibrinolytic drug that helps limit haematoma expansion.   A study was conducted to evaluate the effectiveness and safety of using TXA in NOAC-related ICH...Read more